A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

Governance & financials

The Foundation is an independent non-profit organisation, funded by the UK and Dutch governments, the Bill & Melinda Gates Foundation, AXA Investment Managers, and Wellcome Trust. The Foundation is a registered charity in the Netherlands (ANBI-status).

Leadership and supervision

The Foundation is led by the Executive Board, represented by Jayasree K. Iyer, Executive Director. The Executive Board is responsible for the Foundation’s organisational and strategic development and day-to-day operations. 

The Foundation has a Supervisory Board that oversees the management and strategic direction of the Foundation. The Supervisory Board also has an advisory function. The board meets every quarter and regular agenda topics include: strategy, finance, risk management, and staffing.

Guidelines

The governance and administration of the Access to Medicine Foundation are guided by its Governance Charter, Conflict of Interest Policy, Articles of Association and Code of Ethics documents. These outline the values on which the Foundation is built, including its role and the impact it aims to have on access-to-medicine issues.

Read Code of Ethics
Read Articles of Association
Read the Conflict of Interest Policy

Finances

The Foundation and its work is independently funded by the Foreign, Commonwealth and Development Office of the UK government, the Dutch Ministry of Foreign Affairs, the Bill & Melinda Gates Foundation, the Dutch Ministry of Health, Welfare & Sport and AXA Investment Managers.

The Access to Vaccines Index was funded by the Dutch Postcode Lottery. Income streams are sufficiently diverse and secure in the short to medium term. We are proactively fundraising in order to secure multiple sources of funding for the long term.

Use of funds 2017 – 2021
The most recent Annual Report offers a detailed picture of the financial situation of our organisation. The most important trend in the past two years has been the continuous improvement of the equity position of the Foundation, with real-terms increases in the overall net result. The Foundation’s finances are audited annually by an independent external auditor and overseen by the Supervisory Board, which is independent from the Foundation's Executive Board.

Download the 2019 Annual Report

ANBI-relevant information

The Access to Medicine Foundation is officially a registered charity in the Netherlands (known as ANBI-status).

Registered name
Stichting Access to Medicine Foundation

RSIN number
812076114

Chamber of Commerce registration
34185938

Address
Access to Medicine Foundation
Naritaweg 227-A
1043 CB Amsterdam
The Netherlands
+31 20 215 3535

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |